Your browser doesn't support javascript.
Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).
Sereti, Irini; Shaw-Saliba, Kathryn; Dodd, Lori E; Dewar, Robin L; Laverdure, Sylvain; Brown, Shawn; Mbaya, Olivier Tshiani; Muyembe Tamfum, Jean Jacques; Mblala-Kingebeni, Placide; Sow, Ydrissa; Akpa, Esther; Haidara, Mory Cherif; Fouth Tchos, Karine; Beavogui, Abdoul Habib; Neal, Aaron; Arlinda, Dona; Lokida, Dewi; Grue, Louis; Smolskis, Mary; McNay, Laura A; Gayedyu-Dennis, Dehkontee; Ruiz-Palacios, Guillermo M; Montenegro-Liendo, Abelardo; Tounkara, Moctar; Samake, Seydou; Jargalsaikhan, Ganbolor; Zulkhuu, Delgersaikhan; Weyers, Shera; Bonnett, Tyler; Potter, Gail E; Stevens, Randy; Rupert, Adam; Aboulhab, Jamila; Biampata, Jean-Luc; Delamo, Alexandre; Camara, Bienvenu Salim; Kosasih Indonesia, Herman; Karyana, Muhammad; Duworko, James T; Regalado-Pineda, Justino; Guerra-de-Blas, Paola Del Carmen; Doumbia, Seydou; Dabitao, Djeneba; Dashdorj, Naranjargal; Dashdorj, Naranbaatar; Newell, Kevin; Francis, Alyson; Rubenstein, Kevin; Bera, Victoria; Gulati, Iman.
  • Sereti I; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Shaw-Saliba K; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Dodd LE; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Dewar RL; Virus Isolation and Serology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Laverdure S; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Brown S; AIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Mbaya OT; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Muyembe Tamfum JJ; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of Congo.
  • Mblala-Kingebeni P; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of Congo.
  • Sow Y; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Akpa E; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Haidara MC; Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
  • Fouth Tchos K; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Beavogui AH; Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
  • Neal A; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Arlinda D; Ministry of Health, Jakarta, Indonesia.
  • Lokida D; Indonesia Research Partnership on Infectious Diseases National Institute of Health Research and Development, Jakarta, Indonesia.
  • Grue L; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Smolskis M; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • McNay LA; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Gayedyu-Dennis D; Partnership for Research on Vaccines and Infectious Diseases in Liberia, Monrovia, Liberia.
  • Ruiz-Palacios GM; Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico.
  • Montenegro-Liendo A; The Mexican Emerging Infectious Diseases Clinical Research Network, Ciudad de México, Mexico.
  • Tounkara M; University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Samake S; University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Jargalsaikhan G; The Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
  • Zulkhuu D; The Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
  • Weyers S; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Bonnett T; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Potter GE; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Stevens R; AIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Rupert A; AIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Aboulhab J; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
  • Biampata JL; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of Congo.
  • Delamo A; Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
  • Camara BS; Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maférinya, Guinea.
  • Kosasih Indonesia H; Indonesia Research Partnership on Infectious Diseases National Institute of Health Research and Development, Jakarta, Indonesia.
  • Karyana M; Ministry of Health, Jakarta, Indonesia.
  • Duworko JT; Partnership for Research on Vaccines and Infectious Diseases in Liberia, Monrovia, Liberia.
  • Regalado-Pineda J; Subdirección de Medicina, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México, Mexico.
  • Guerra-de-Blas PDC; The Mexican Emerging Infectious Diseases Clinical Research Network, Ciudad de México, Mexico.
  • Doumbia S; University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Dabitao D; University Clinical Research Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
  • Dashdorj N; The Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
  • Dashdorj N; The Liver Center, Mongolia and Onom Foundation, Ulaanbaatar, Mongolia.
  • Newell K; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Francis A; Systex, Inc, Rockville, Maryland, United States of America.
  • Rubenstein K; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Bera V; Systex, Inc, Rockville, Maryland, United States of America.
  • Gulati I; Systex, Inc, Rockville, Maryland, United States of America.
PLoS One ; 17(9): e0273914, 2022.
Article in English | MEDLINE | ID: covidwho-2029779
ABSTRACT
In response to the COVID-19 pandemic, COVID-19 vaccines have been developed, and the World Health Oraganization (WHO) has granted emergency use listing to multiple vaccines. Studies of vaccine immunogenicity data from implementing COVID-19 vaccines by national immunization programs in single studies spanning multiple countries and continents are limited but critically needed to answer public health questions on vaccines, such as comparing immune responses to different vaccines and among different populations.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0273914

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0273914